Warhound raises $200M to build genetically edited military dogs

TechCrunch reports that Warhound, a startup conceived by Anduril's Palmer Luckey and Colossal Biosciences' Ben Lamm, has come out of stealth with $200 million in funding at a $1.2 billion valuation. The plan is to gene-edit and clone working dogs for the military, law enforcement and emergency response. Investors named include Sequoia, 8VC, Corner Ventures and In-Q-Tel. Wired says the breeds will be mostly Belgian Malinois, with some labs and shepherds, and that Lamm expects the first puppies in early 2027. Anduril would supply gear such as protective vests and goggles.

Outlets agree on the funding, the Texas base and the fact that the dogs don't exist yet. The valuation comes from TechCrunch alone. On ownership, Wired and TechCrunch relay Lamm saying Luckey holds no equity, Wired adds that Anduril holds none, and The Verge cites Bloomberg for Luckey having no ongoing role. The outlets differ on timing: Wired describes gene editing of a first batch as under way, while TechCrunch says that batch is about to be cloned. Nobody has published which genes are being edited, the method, the number of animals, or any welfare data. Lamm told Wired he can't speak for Anduril's plans and that the near-term tools are body armor, not implanted computers.

My Read: Are we making better dogs, or just dogs that are better for us? I see the benefits of genetic engineering, especially when targeted at eliminating inherited disease, at extending life. But engineering dogs for military performance raises serious ethical questions. We've seen where this can lead. Commercial chickens have been selectively bred to grow so quickly that many develop mobility problems. Bulldogs bred for what we find cute or appealing, even when those traits leave them struggling to breathe and shorten their lives. In both cases, we've prioritized a solution to a perceived human "user need" over the animal's wellbeing.

Now we're moving beyond canine selective breeding, directly editing the genes of working dogs. What happens when an experiment fails? What happens to dogs that don't meet expectations? Who's responsible for their long-term health? I'm not against the technology, but this is a slippery slope. History has shown getting these things right involves trial and error—and it's a living, feeling animal that may pay the price. Are we about to repeat the same mistakes made with selective breeding, this time with gene editing at scale?